Stoke Therapeutics, Inc. (STOK) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "STOK"
      ],
      "issuer_cik": "0001623526",
      "owner_cik": "0001966716",
      "accession_number": "0001966716-26-000014",
      "form_type": "4",
      "filing_date": "2026-10-02",
      "period_of_report": "2026-10-02",
      "issuer_name": "Stoke Therapeutics, Inc.",
      "issuer_trading_symbol": "STOK",
      "owner_name": "Allan Jonathan",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "GENERAL COUNSEL & CORP SEC",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-02",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 627,
      "transaction_price_per_share": 26.33,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 20598,
      "transaction_value": 16508.91,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."
        }
      ]
    },
    {
      "tickers": [
        "STOK"
      ],
      "issuer_cik": "0001623526",
      "owner_cik": "0001780088",
      "accession_number": "0001780088-26-000023",
      "form_type": "4",
      "filing_date": "2026-10-02",
      "period_of_report": "2026-10-01",
      "issuer_name": "Stoke Therapeutics, Inc.",
      "issuer_trading_symbol": "STOK",
      "owner_name": "Ticho Barry",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "CHIEF MEDICAL OFFICER",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-01",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 1051,
      "transaction_price_per_share": 26.1594,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 19059,
      "transaction_value": 27493.529400000003,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2025."
        },
        {
          "id": "F2",
          "description": "The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.91 to $26.51 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.